Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 2:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 2,531 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Baseline Control Clear all

Conditions: Caregiver Burden, Cannabis Use, Expressed Emotion, Communications Skills
Interventions: Cannabis Conversation Skills for Families (CCSF); Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Long COVID
Interventions: Biosound Therapy System; Device
Lead sponsor: Anxiety Relief Center; Other
Eligibility: 20 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Fishers, Indiana

Conditions: Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6, Spinocerebellar Ataxia Type 7
Interventions: High-Intensity Aerobic Exercise Prior to Balance Training, Low-Intensity Exercise Prior to Balance Training; Behavioral
Lead sponsor: Teachers College, Columbia University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Cirrhosis, Liver, End Stage Liver DIsease, Symptoms and Signs, Physical Inactivity, Muscle Loss
Interventions: LiverWatch Intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Philadelphia, Pennsylvania

Conditions: Parkinson's Disease, Freezing of Gait, Cognitive Ability, General
Interventions: Droxidopa, sugar pill; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 30 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Chicago, Illinois • West Bloomfield, Michigan

Conditions: Autism Spectrum Disorder
Interventions: Strengthening Skills Program, PEERS Social Skills Program; Behavioral
Lead sponsor: Southwest Autism Research & Resource Center; Other
Eligibility: 21 Years to 70 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Anxiety
Interventions: App; Behavioral
Lead sponsor: Dharma Life Sciences LLC; Industry
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension, Cardiovascular Diseases, Cardiovascular Risk Factors, Circadian Rhythms, Sleep
Interventions: At-home Polysomnography, Circadian Protocol, Rested Wakefulness Trial, Overnight Sleep Trial, Regularized Sleep Schedule; Other · Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 25 Years to 64 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Plaque Psoriasis
Interventions: JNJ-77242113, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 12 Years and older
Enrollment: 684 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 46
States / cities: Phoenix, Arizona • Fort Smith, Arkansas • Fountain Valley, California + 42 more

Conditions: Thromboembolism of Vein VTE in Colorectal Cancer, Thromboembolism of Vein in Pancreatic Cancer, Thromboembolism of Vein in Non-small Cell Lung Cancer
Interventions: Isoquercetin; Drug
Lead sponsor: Jeffrey Zwicker, MD; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 11
States / cities: Los Angeles, California • Sacramento, California • West Haven, Connecticut + 7 more

Conditions: Central Retinal Vein Occlusion
Interventions: Autologous Bone Marrow CD34+ Stem Cells, Sham Therapy; Biological
Lead sponsor: The Emmes Company, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Chronic Lower Back Pain
Interventions: Structured and tailored PainGuide, Standard PainGuide; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Fall Risk, Healthy Elderly
Interventions: AMES; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 65 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Atherothrombosis
Interventions: Aspirin; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 45 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Rheumatoid Arthritis (RA)
Interventions: Abatacept, Placebo for abatacept (0.9% Sodium Chloride Injection or Solution for Infusion), Upadacitinib, Placebo for upadacitinib; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 657 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 44
States / cities: Peoria, Arizona • Sun City, Arizona • Tucson, Arizona + 40 more

Conditions: Cancer Survivors With Clinically Significant Distress
Interventions: online social-networking intervention; Behavioral
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 347 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Eustachian Tube Dysfunction
Interventions: ET Stress test, Sonotubometry, Forced Response Test (FRT), Inflation Deflation Test (IDT), Maneuver Sequence, 9-Step Test, Tubomanometry, Videoendoscopic assessment of ETF, Pressure chamber ET test; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 3 Years to 70 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Stretch Marks
Interventions: Combination treatment, 1550-nm erbium-doped fractionated laser; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hearing Loss, Cochlear Hearing Loss, Hearing Loss, Sensorineural, Aging
Interventions: Diagnostic tests of cochlear implant function, Diagnostic tests of auditory function; Diagnostic Test
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 18 Years to 85 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: College Park, Maryland

Conditions: Unprotected Sex, Contraceptive Usage
Interventions: Pulse; Behavioral
Lead sponsor: Child Trends; Other
Eligibility: 18 Years to 20 Years · Female only
Enrollment: 2,317 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hearing Disability, Depression, Mobility Disability
Interventions: Sham Digital Program - General health education and interactive quizzes unrelated to depression or CBT., Toivoa-002 - A digital Cognitive Behavioral Therapy program combined with NBHWC-certified coaching.; Device
Lead sponsor: Toivoa Inc; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Dover, Delaware • East Orange, New Jersey • Cleveland, Ohio + 1 more

Conditions: Postural Tachycardia Syndrome (POTS)
Interventions: Pulsitile Arterial Tonometry (PAT) Protocol, Calf Blood Flow in Reactive Hyperemia (CBF-RH), Evaluation of Forearm-Mediated Dilation; Procedure · Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Weight Loss
Interventions: Weight loss Groups; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: HIV
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Skills for Talking About Cannabis for Families of Young Adults With Psychosis

Biosound Therapy as a Treatment for Long COVID Patients

Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

Strengthening Skills Behavioral Intervention for Adults With Autism Spectrum Disorder

Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial

Sleep and Circadian Mechanisms in Hypertension

A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

Cancer Associated Thrombosis and Isoquercetin (CATIQ)

Treatment of Central Retinal Vein Occlusion Using Stem Cells Study

Tailored Pain Guide (TPG) Study

Training the Brain with a Robotic Device for Balance Recovery

Pharmacogenomics of Antiplatelet Response - II (PARes-II)

A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Evaluation of a Social-networking Intervention to Reduce Cancer-related Distress

Gas Supply, Demand and Middle Ear Gas Balance -- Diagnosis of Eustachian Tube Dysfunction

Fractional Laser and Ultrasound for Striae Distensae

Peripheral and Central Influences on Auditory Temporal Processing & Speech Perception in Older Cochlear Implantees

The Evaluation of Pulse: A Mobile Health App and Teen Pregnancy Prevention Program

Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching

Effect of Dietary Sodium Intake on Vascular Endothelium

Impact of Volunteer Peer-Led Intervention for Weight Control in Primary Care

Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients